Association between moderate clinical activity and stricturing behaviour, p = 0.001. Table S3 . Distribution of the clinical activity of disease at baseline in patients with distal/left-sided colitis or extensive ulcerative colitis.
Variable UC patients with distal/leftsided colitis (n = 40)
UC patients with extensive colitis (n = 67) Χ 2
Mild Clinical Activity 13 (32%) 18 (27%) p = 0.534 Moderate Clinical Activity 24 (60%) 40 (60%) p = 0.975 Severe Clinical Activity 3 (8%) 9 (13%) p = 0.346 Χ 2/ Fisher test male gender, n (%) 11 (65%) 15 (37%) p = 0.059 young age at diagnosis (<40 years), n (%) 13 (76%) 33 (82%) p = 0.597 long standing disease (≥8 years), n (%) 16 (94%) 29 (72%) p = 0.067 perianal disease, n (%) 6 (35%) 12 (30%) p = 0.694 prior ileo-colonic resection, n (%) 12 (71%) 25 (62%) p = 0.558 smoking status, n (%) Never 10 (59%) 15 (37%) p = 0.137 Former 3 (18%) 13 (32%) p = 0.253 Current 4 (23%) 12 (31%) p = 0.618 prior immunosuppressive therapy, n (%) 11 (65%) 32 (80%) p = 0.219 prior TNF antagonist, n (%) 13 (76%) 35 (87%) p = 0.296 concomitant steroids during the induction, n (%) 8 (46%) 21 (52%) p = 0.706 concomitant immunosuppressive therapy during the induction, n (%) 1 (6%) 4 (10%) p = 0.615 mild clinical activity (HBI 5-7), n (%) 11 (65%) 7 (18%) p = 0.0004 moderate clinical activity , n (%) 6 (35%) 31 (77%) p = 0.002 severe disease activity (HBI >16), n (%) 0 2 (5%) p = 1 CRP >5 mg/L, n (%) 9 (53%) 23 (57%) p = 0.751 male gender, n (%) 21 (62%) 24 (51%) p = 0.338 young age at diagnosis (<40 years), n (%) 25 (73%) 34 (72%) p = 0.905 long standing disease (≥8 years), n (%) 25 (73%) 35 (74%) p = 0.924 smoking status, n (%) never 25 (73%) 33 (70%) p = 0.743 former 5 (15%) 9 (19%) p = 0.601 current 4 (12%) 5 (11%) p = 0.873 prior immunosuppressive therapy, n (%) 25 (73%) 33 (70%) p = 0.743 prior TNF antagonist, n (%) 27 (79%) 37 (79%) p = 0.940 concomitant steroids during the induction, n (%) 22 (65%) 31 (66%) p = 0.906 concomitant immunosuppressive therapy during the induction, n (%) 3 (9%) 2 (4%) p = 0.399 mild clinical activity (pMayo 2-4), n (%) 13 (38%) 14 (30%) p = 0.426 moderate clinical activity (pMayo 5-7), n (%) 21 (62%) 24 (51%) p = 0.338 severe disease activity (pMayo 8-9), n (%) 0 9 (19%) p = 0.008 CRP >5 mg/L, n (%) 20 (59%) 28 (59%) p = 0.945
Distal/Left-sided colitis 21 (62%) 9 (19%) p = 0.00008 Extensive Colitis 13 (38%) 38 (81%) p = 0.00008
